|
TMEM165 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.157600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.335700E-02 |
| Normal-vs-Stage2 |
6.417200E-01 |
| Normal-vs-Stage3 |
8.901800E-01 |
| Normal-vs-Stage4 |
3.340200E-01 |
| Stage1-vs-Stage2 |
2.778400E-01 |
| Stage1-vs-Stage3 |
1.429770E-01 |
| Stage1-vs-Stage4 |
1.988470E-02 |
| Stage2-vs-Stage3 |
6.016200E-01 |
| Stage2-vs-Stage4 |
1.929560E-01 |
| Stage3-vs-Stage4 |
4.760200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.049800E-01 |
| Normal-vs-AfricanAmerican |
6.840000E-01 |
| Normal-vs-Asian |
9.709000E-01 |
| Caucasian-vs-AfricanAmerican |
8.637000E-01 |
| Caucasian-vs-Asian |
8.308800E-01 |
| AfricanAmerican-vs-Asian |
8.080200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.408600E-01 |
| Normal-vs-Female |
2.133200E-01 |
| Male-vs-Female |
2.895200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.615200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.349800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.361200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.796590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.259600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.663400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.006600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.664800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.833600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.384600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.963200E-01 |
| Normal-vs-Grade 2 |
3.281600E-01 |
| Normal-vs-Grade 3 |
3.848000E-01 |
| Normal-vs-Grade 4 |
3.959000E-01 |
| Grade 1-vs-Grade 2 |
9.950000E-01 |
| Grade 1-vs-Grade 3 |
9.297200E-01 |
| Grade 1-vs-Grade 4 |
1.943180E-01 |
| Grade 2-vs-Grade 3 |
8.950800E-01 |
| Grade 2-vs-Grade 4 |
8.209700E-02 |
| Grade 3-vs-Grade 4 |
1.156570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.682500E-03 |
| Normal-vs-ccB subtype |
3.659400E-01 |
| ccA subtype-vs-ccB subtype |
3.563100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.875600E-01 |
| Normal-vs-N1 |
1.855580E-01 |
| N0-vs-N1 |
1.754410E-01 |
|
|
